In the per-protocol analysis , 28 first-degree relatives ( 3.9 % ) in the FIT group and 43 ( 5.8 % ) in the colonoscopy group had advanced neoplasia ( odds ratio = 1.56 ; 95 % confidence interval : 0.95-2 .56 ; P = .08 ) .